Ivermectin, Mexico, Peru, India

Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City Case study: Policy intervention in Mexico City Increase in COVID-19 cases and with critical levels of hospital saturation during December 2020 Mexico City Government decided to expand population-based health Interventions Implementation of a prehospital home-care program Combining early detection with antigen tests 230 kiosks Phone-based follow up for positive patients Since 28 December, 2020, medical ivermectin kits have been provided to positive mild to moderate symptomatic patients Dyspnea, chest pain or cyanosis, referred to a hospital Ivermectin, four 6mg tablets, two pills for two days After one month, 83,000 medical kits delivered Detailed data was collected on the evolution of patient illnesses Quasi-experimental evaluation of the effects of the medical kits on hospitalization Kit receivers and non-